Advanced in Metastatic Brain Tumor

Kuo-chen Wei

Taoyuan, TNQ, TW 
Advanced in Metastatic Brain Tumor
Taoyuan, TNQ, TW 
OverviewLocationsClinical Research

Overview

Kuo-chen Wei practices in Taoyuan, Taiwan. Wei is rated as an Advanced expert by MediFind in the treatment of Metastatic Brain Tumor. Their top areas of expertise are Brain Abscess, Glioma, Gliomatosis Cerebri, Awake Craniotomy, and Craniectomy.

Their clinical research consists of co-authoring 174 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Metastatic Brain Tumor.

Locations

Taoyuan, TNQ, Taiwan
Other Locations
Tucheng, TPQ 23601, Taiwan
No. 5, Fuxing St, Taoyuan City 333423, Taoyuan City, TNQ 33342, Taiwan
Keelung, TNQ, Taiwan
Linkou, TPQ, Taiwan
Taiwan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Phase 1-2 Trial of ADI-PEG 20 Plus Radiotherapy and Temozolomide in Subjects With Newly Diagnosed Glioblastoma Multiforme (GBM)
Phase 1-2 Trial of ADI-PEG 20 Plus Radiotherapy and Temozolomide in Subjects With Newly Diagnosed Glioblastoma Multiforme (GBM)
Enrollment Status: Active_not_recruiting
Publish Date: August 26, 2025
Intervention Type: Drug
Study Drugs: ADI-PEG20, Temozolomide
Study Phase: Phase 2
A Phase I Study of CAN008 Plus Concomitant Temozolomide During and After Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme
A Phase I Study of CAN008 Plus Concomitant Temozolomide During and After Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme
Enrollment Status: Completed
Publish Date: November 08, 2018
Intervention Type: Drug
Study Phase: Phase 1
View 1 Less Clinical Trial

174 Total Publications

Acrolein-induced PKM2 modification drives NETosis and glioma progression.
Acrolein-induced PKM2 modification drives NETosis and glioma progression.
Journal: Free radical biology & medicine
Published: August 17, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Wei's expertise for a condition
ConditionClose
    View All 7 Distinguished Conditions
    View All 32 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile